Xiao, Huijie <br/><br/>
Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate             in pancreatic cancer cells.  [electronic resource] 

 -  Oncology reports  Jan 2013 
 - 329-34 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2012.2085  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--metabolism<br/>Antimetabolites--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Cell Hypoxia--drug effects<br/>Cell Proliferation--drug effects<br/>Deoxyglucose--pharmacology<br/>Drug Synergism<br/>Enzyme Inhibitors--pharmacology<br/>Fumarates--metabolism<br/>Humans<br/>Hypoxia-Inducible Factor 1, alpha Subunit--antagonists & inhibitors<br/>Mitochondria--drug effects<br/>Pancreatic Neoplasms--drug therapy<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Pyruvate Dehydrogenase Complex--antagonists & inhibitors<br/>Pyruvates--pharmacology<br/>RNA, Small Interfering--genetics<br/>Superoxide Dismutase--metabolism<br/>Tumor Cells, Cultured